Patent and Intellectual Property Litigation Reporting

Patent DocumentsAfter more than three decades of specializing in reporting complex matters in patent litigation, Wilcox & Fetzer’s staff has earned a reputation among intellectual property attorneys for providing accurate transcripts with quick turnaround deadlines.  Upon request, our reporters can also provide either a realtime feed or rough draft of the proceedings so counsel can have an instant working draft of each day’s proceedings.  All of our staff reporters assigned to patent cases are nationally certified and have over 25 years experience in covering patent cases in a wide range of subjects, including pharmaceutical, biotech, information technology (hardware/software), telecommunications, biophysics and genomics, among others.  Our reporters meticulously review patents, complaints, pleadings, and other available materials necessary to gain familiarity with the industry-specific terminology, enabling them to provide accurate transcripts.


A small sample of the patent cases we have worked on appears below:

  • Ricoh Company, Ltd. v Oki Data Corp.
  • Ciba Specialty Chemicals v Hercules, Inc.
  • EMD Millipore Corp. v W.L. Gore & Associates, Inc.
  • Butamax Advanced Biofuels v Gevo, Inc.
  • Pfizer, Inc. v Mylan Pharmaceuticals, Inc.
  • Pfizer, Inc. v Dr. Reddy’s Laboratories, Ltd.
  • Cephalon, Inc.  v Watson Pharmaceuticals, Inc.
  • Akzo v DuPont
  • Ampex Corp v Eastman Kodak
  • Monsanto Company, LLC v Syngenta Seeds, Inc.
  • Netcraft Corp. v AT&T, Inc.
  • Perdue Pharma Products, LP v Par Pharmaceutical, Inc.
  • Synthes USA, LLC, et al.,  v Globus Medical, Inc.
  • Zenith Products Corp.  v Design Home Solutions
  • Ladatech, LLC.  v Illumina, Inc. and Solexa, Inc.
  • Parker-Hannifin Corp.  v Champion Laboratories, Inc.
  • Scieran Technologies, Inc.  v Bausch & Lomb, Inc.
  • Ledergerber Medical Innovations v W.L. Gore Associates, Inc.
  • Kenexa Brassring, Inc.  v Taleo Corp.
  • Mark IV Industries Corp.  v Transcore Holdings, Inc.
  • Cornell University, et al. v Illumina, Inc.

Comments are closed.